Stockholm, May 8 -- Swedish pharmaceutical giant AstraZeneca is recalling its COVID-19 vaccine, sold under the brand names Covishield and Vaxzevria, among others, from sale worldwide, the local newspaper reported, citing the company.
The application for the vaccine's withdrawal from the European Union was submitted on March 5 and entered into effect on Tuesday, with similar applications expected to be filed in the coming months in the United Kingdom and in other countries where it had been approved, the newspaper wrote on Tuesday.
"We will partner with regulatory authorities globally to initiate marketing authorization withdrawals for Vaxzevria, where no future commercial demand for the vaccine is expected," the company was quoted as sayi...